Basic information about inhibitors

IPAD-DB ID	C00788
Name	Melatonin
Category	Natural compounds
2D Structure
3D Structure
Molecular Formula	C 1 3 H 1 6 N 2 O 2
Molecular Weight	232.28g/mol
IUPAC Name	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide
InChI	InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4, 7-8, 15H, 5-6H2, 1-2H3, (H, 14, 16)
InChIKey	DRLFMBDRBRZALE-UHFFFAOYSA-N
Canonical SMILES	CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC
PubChem CID	896
DrugBank Accession Number	-
CAS Registry Number	73-31-4, 8041-44-9

Biological activity data

Ki	-
EC50	-
IC50	-
Inhibition	-
Toxicity	-
ROS(reactive oxygen species)	-
Metal Chelating	-
BBB(blood-brain barrier)	-
Target Protein	Aβ1-42
Effects	(1) Aβ level and Aβ1-42 induced BACE-1 expression in the Aβ 1-42-treated mice was overcome and alleviated by melatonin treatment, (2)melatonin attenuates tau hyperphosphorylation through the regulation of PI3/Akt/GSK-3bsignaling pathway, (3)melatonin prevents Aβ1-42-induced apoptosis and neurodegeneration by reducing activated caspase-9, caspase-3, and PARP-1 cleavage and FJB-positive neurons,
Research Models	Neuronal HT22 cells, C57BL/6N mice,
Main Source	From pineal gland
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME)	232.28
Hac(Computed by SwissADME)	17
Volume(Computed by ADMETlab 2.0)	242.683
Density(Computed by ADMETlab 2.0)	0.956
nRing(Computed by ADMETlab 2.0)	2
MaxRing(Computed by ADMETlab 2.0)	2
nHet(Computed by ADMETlab 2.0)	4
fChar(Computed by ADMETlab 2.0)	0
nRig(Computed by ADMETlab 2.0)	11
Flexibility(Computed by ADMETlab 2.0)	0.455
Stero Centers(Computed by ADMETlab 2.0)	0
LogS(Computed by ADMETlab 2.0)	-1.995
LogD(Computed by ADMETlab 2.0)	1.462

ADMET properties

logP(Computed by ADMETlab 2.0)	1.346
TPSA(Computed by SwissADME)	54.12
Hbond Acceptor(Computed by SwissADME)	2
Hbond Donor(Computed by SwissADME)	2
Rotatable Bonds(Computed by SwissADME)	5

Pharmacokinetics

GI Absorption(Computed by SwissADME)	High
BBB(blood-brain barrier) Permeant(Computed by SwissADME)	Yes
P-gp Substrate(Computed by SwissADME)	No
CYP1A2 Inhibitor(Computed by SwissADME)	Yes
CYP2C19 Inhibitor(Computed by SwissADME)	No
CYP2C9 Inhibitor(Computed by SwissADME)	No
CYP2D6 Inhibitor(Computed by SwissADME)	No
CYP3A4 Inhibitor(Computed by SwissADME)	No
log Kp(Skin Permeation)(Computed by SwissADME)	-6.59

Druglikeness

Lipinski(Computed by SwissADME)	0
Ghose(Computed by SwissADME)	0
Veber(Computed by SwissADME)	0
Egan(Computed by SwissADME)	0
Muegge(Computed by SwissADME)	0
Bioavailability Score(Computed by SwissADME)	0.55